Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
MindMatters Stories: Research
Meet ABTA’s Eight Newest Summer Research Fellows
The ABTA is proud to announce eight recipients of the Medical Student Summer Fellowship grants.
Join a Brain Tumor 5k Run & Walk Near You this Fall
You can make a difference and raise critical funds for research by joining a Breakthrough for Brain Tumors 5k Run & Walk event.
Your Long-Time Brain Tumor Champion Ups Its Game in Washington
With the reigniting of the White House’s Cancer Moonshot Initiative, the ABTA recently joined the Brain Cancers Forum in Washington, D.C., to discuss opportunities in discovering treatments for brain cancers, including GBM.
First Targeted Therapy for Glioma Headed for FDA Approval
A first-in-class targeted therapy for low-grade glioma could gain FDA approval as early as spring 2024. Here are three things you should know about the emerging drug “vorasidenib.”
“Doing Hard Things” Community Bands Together to Drive Kelli McLaughlin’s Legacy Forward
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
Together, Let’s Meet Hope Head On
Discover how you can play a role in the ABTA’s five-year campaign “Meet Hope Head On.”
Taking Control of Your Brain Metastases Care
Join a free, half-day virtual meeting for patients and families dealing with brain metastases, led by Priya Kumthekar, MD, Director of the Brain Metastases Program at Northwestern University.
2023 ABTA National Conference Returns To Chicago
Register now for the nation’s largest patient-centric brain tumor conference, returning to Chicago and online this September.
